• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Kymera stock surges on product pipeline update

by January 14, 2025
written by January 14, 2025

On Tuesday, Kymera Therapeutics shares leaped 12% following the biotechnology firm’s update on its product pipeline.

The New York-based company announced progress in its programs for atopic dermatitis (AD) and asthma, which has sparked a positive response in the market.

Kymera, focused on advancing protein degradation therapeutics, intends to release preliminary data from its STAT6 degrader program, known as KT-621, within the second quarter.

Additionally, the company is poised to progress into a Phase 1b clinical trial for AD, with results expected to be disclosed in the fourth quarter of this year.

The company’s roadmap includes initiating mid-stage trials for both AD and asthma treatments. These trials are scheduled to commence in late 2025 and early 2026, respectively, marking significant milestones in Kymera’s strategic development plan.

In its pursuit of novel therapeutics, Kymera is not only working on the STAT6 degrader but is also developing a TYK2 degrader and an IRAK4 degrader.

The latter is being developed in collaboration with the pharmaceutical giant Sanofi (NASDAQ:SNY), showcasing the company’s commitment to forging strategic partnerships in the industry.

Kymera also revealed plans to announce its next immunology program within the first half of the current year.

Kymera has reassured stakeholders of its financial stability, reiterating an expected cash runway that will sustain operations into mid-2027, thereby underlining the company’s confidence in its long-term strategy and ongoing research initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
US airline industry lobbying group chief retiring at end of year
next post
Colonial shuts pipeline due to potential gasoline leak

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Trump implies government could cut contracts and subsidies to Musk’s companies

      June 7, 2025
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 6, 2025
    • Shein and Temu see U.S. demand plunge as loophole for cheap goods closes

      June 5, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (505)
    • Stock (6,426)

    Latest News

    • Trump implies government could cut contracts and subsidies to Musk’s companies
    • Procter & Gamble to cut 7,000 jobs as part of broader restructuring

    Popular News

    • European shares settle at one-month high; French politics in focus
    • Bayer cuts FY operating earnings outlook on weak agriculture markets

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy